A study of effects of using low dialysate calcium concentration (1.50 mmol/L) on blood pressure,serum concentrations of calcium,parathyroid hormone and aldosterone in chronic hemodialysis patients

被引:0
|
作者
范凯文 [1 ]
许晨 [1 ]
朱敏 [1 ]
机构
[1] Dialysis Center,Nephrology Department of Tongji Hospital Affiliated to Tongji University
关键词
dialysate concentration; hemodialysis; parathyroid hormone; calcium; aldosterone;
D O I
暂无
中图分类号
R459.5 [透析疗法];
学科分类号
100215 ;
摘要
Background: Dialysis centres around the world use different concentrations of calcium in dialysate solution,ranging from 1. 25 to 1. 75 mmol / L. However,a dialysate concentration of 1. 25 mmol / L is recommended. [1] Higher or lower dialysate calcium concentrations are indicated in patients,depending on their co-morbid factors. We explored the effects of using a calcium dialysate solution of 1. 50 mmol / L compared to a 1. 75 mmol / L calcium dialysate solution on the Blood Pressure (BP) ,serum concentrations of Calcium,Parathyroid Hormone (PTH) and Aldosterone in chronic hemodialysis (HD) patients. Method: 42 patients were enrolled in the study. First a 1. 50 mmol / L low calcium dialysate solution (LCDS) was used for 4 hour dialysis,and for the next session of HD,a 1. 75 mmol / L (NCDS) normal calcium dialysate solution was used. Blood pressure was measured at 5 intervals of time: pre HD,at 60,120,180 and 240 minutes into the HD session. Pre and post HD blood samples were taken for serum calcium,PTH and Aldosterone levels. Results: All 42 patients completed the study. With LCDS,the post HD serum calcium levels were (2. 51 ± 0. 14) mmol / L,compared to (2. 85 ± 0. 17) mmol / L for NCDS (P < 0. 01) . A post HD serum PTH level of (80. 6 ± 144. 93) pg / ml was observed when using LCDS,whereas a (52. 25 ± 115. 89) pg / ml serum PTH level was noted with NCDS (P < 0. 01) . As for aldosterone,a post HD value of (161. 77 ± 80. 42) ng / L was obtained with LCDS and (165. 50 ± 78. 84) ng / L with NCDS (P < 0. 01) . The mean post HD systolic blood pressure was (129. 17 ± 25. 42) mmHg with LCDS dialysis compared to (132. 50 ± 20. 32) mmHg for NCDS dialysis (P < 0. 01) and the diastolic BP values observed were (75. 10 ±10. 34) mmHg and (78. 26 ±11. 63) mm Hg(P <0. 01) ,respectively. Conclusion: LCDS can more effectively improve hypercalcemic status in dialysis patients than NCDS. Using LCDS stimulates the secretion of PTH more than when using NCDS. LCDS decreases aldosterone levels more than NCDS. Patients undergoing dialysis with LCDS have a lower post dialysis BP compared to those using NCDS. LCDS has a greater effect in decreasing both the post systolic and diastolic blood pressure than NCDS. Serum calcium,PTH and aldosterone levels have a greater decreasing effect on BP in LCDS than NCDS. Dialysate calcium profiling might be used as a means of therapy to control hypercalcemia, especially in patients who are hemodynamically stable.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 50 条
  • [21] EFFECTS OF ORAL BASE THERAPY ON SERUM IONIZED CALCIUM, PHOSPHORUS AND PARATHYROID-HORMONE IN CHRONIC-HEMODIALYSIS PATIENTS
    CARUANA, RJ
    WEINSTEIN, RS
    CAMPBELL, HT
    CHAUDHARY, BA
    SMITH, KL
    KURUNSAARI, KM
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1989, 12 (12): : 778 - 781
  • [22] Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients
    Merle, Emilie
    Roth, Hubert
    London, Gerard M.
    Jean, Guillaume
    Hannedouche, Thierry
    Bouchet, Jean-Louis
    Drueeke, Tilman
    Fouque, Denis
    Daugas, Eric
    [J]. KIDNEY INTERNATIONAL, 2016, 89 (03) : 666 - 674
  • [23] Effect of low-calcium and standard-calcium dialysate on serum calcium, phosphorus and full-segment parathyroid hormone in patients on peritoneal dialysis: A retrospective observational study
    An, Ning
    Zhou, Haishan
    Li, Xianhui
    Yu, Xinyin
    Yang, Haijuan
    Zhai, Liping
    Huang, Yuhua
    Yao, Cuiwei
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2023, 46 (10-11): : 539 - 546
  • [24] Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Tromso study
    Jorde, R
    Bonaa, KH
    Sundsfjord, J
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 141 (04) : 350 - 357
  • [25] The low-calcium concentration of dialysate induced markedly an increase of serum parathyroid hormone in a continuous ambulatory peritoneal dialysis patient
    Yokoyama, K.
    Yoshida, H.
    Kato, J.
    Ilda, R.
    Kawamura, Y.
    Yamamoto, H.
    Hosoya, T.
    [J]. KIDNEY INTERNATIONAL, 2007, 71 (06) : 594 - 594
  • [26] EFFECTS OF SERUM CALCIUM, PHOSPHORUS AND PARATHYROID HORMONE CONCENTRATIONS ON GLUCOSE METABOLISM IN PATIENTS WITH ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM
    Baser, H.
    Tuzun, D.
    Saglam, F.
    Dirikoc, A.
    Aydin, C.
    Ersoy, R.
    Cakir, B.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2013, 9 (03) : 377 - 384
  • [27] THE EFFECTS OF CALCIUM-CARBONATE AS THE SOLE PHOSPHATE BINDER IN COMBINATION WITH LOW CALCIUM DIALYSATE AND CALCITRIOL THERAPY IN CHRONIC-HEMODIALYSIS PATIENTS
    OETTINGER, CW
    OLIVER, JC
    MACON, EJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1992, 3 (04): : 995 - 1001
  • [28] Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium The Multi-Ethnic Study of Atherosclerosis
    Inoue, Kosuke
    Goldwater, Deena
    Allison, Matthew
    Seeman, Teresa
    Kestenbaum, Bryan R.
    Watson, Karol E.
    [J]. HYPERTENSION, 2020, 76 (01) : 113 - 120
  • [29] Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: A prospective study
    Movilli, E
    Zani, R
    Carli, O
    Sangalli, L
    Pola, A
    Camerini, C
    Scolari, F
    Cancarini, GC
    Maiorca, R
    [J]. NEPHRON, 2001, 87 (03): : 257 - 262
  • [30] ACUTE EFFECT OF DIALYSATE CALCIUM-CONCENTRATION AND INTRAVENOUS VITAMIN-D(3) ON THE SECRETION OF PARATHYROID-HORMONE IN HEMODIALYSIS-PATIENTS
    SAHA, H
    PIETILA, K
    MUSTONEN, J
    PASTERNACK, A
    MORSKY, P
    [J]. CLINICAL NEPHROLOGY, 1992, 38 (03) : 145 - 148